Showing results (101-110 of 212) with videos related to
Sort By:
Pageof 22
The Israel Medical Association Journal : IMAJ|May 12, 2007
The management, early and one year outcome in hospitalized patients with heart failure: a national Heart Failure Survey in Israel--HFSIS 2003Moshe Garty, Avraham Shotan, Shmuel Gottlieb, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.European Heart Journal|October 20, 2009
Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS)Avraham Shotan, Moshe Garty, David S Blondhein, et al.JAMA|September 7, 2005
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY studyMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.The Lancet. Diabetes & Endocrinology|June 6, 2014
Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trialTali Cukierman-Yaffe, Jackie Bosch, Rafael Diaz, et al.Circulation|September 25, 2003
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) studyRon J G Peters, Shamir R Mehta, Keith A A Fox, et al.Journal of the American College of Cardiology|July 10, 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre-Amione, James B Young, Wilson S Colucci, et al.Journal of the American Heart Association|July 20, 2016
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50Stephen K Kidd, Marc P Bonaca, Eugene Braunwald, et al.European Journal of Preventive Cardiology|November 6, 2012
Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East studyAbdurrazzak A Gehani, Ali T Al-Hinai, Mohammad Zubaid, et al.Journal of the American College of Cardiology|June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.Pageof 22